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Abstract 
The role of dopaminergic (DA) projections from the ventral tegmental area (VTA) in appetitive 
and rewarding behavior has been widely studied, but the VTA also has documented DA-
independent functions.  Several drugs of abuse, including nicotine, act on VTA GABAergic 
neurons, and most studies have focused on local inhibitory connections. Relatively little is 
known about VTA GABA projection neurons and their connections to brain sites outside the 
VTA.  In this study, we employed viral-vector mediated cell-type specific anterograde tracing, 
classical retrograde tracing and immunohistochemistry to characterize VTA GABA efferents 
throughout the brain.  We found that VTA GABA neurons project widely to forebrain and 
brainstem targets, including the ventral pallidum, lateral and magnocellular preoptic nuclei, 
lateral hypothalamus and lateral habenula.  Minor projections also go to central amygdala, 
mediodorsal thalamus, dorsal raphe and deep mesencephalic nuclei, and sparse projections go to 
prefrontal cortical regions and to nucleus accumbens shell and core.  Importantly, these 
projections differ from the major VTA DA target regions. Retrograde tracing studies confirmed 
results from the anterograde experiments and differences in projections from VTA subnuclei. 
Retrogradely-labeled GABA neurons were not numerous and most non-TH/retrogradely labeled 
cells lacked GABAergic markers.  Many non-DA/retrogradely labeled cells projecting to several 
areas express VGluT2. VTA GABA and glutamate neurons project throughout the brain, most 
prominently to regions with reciprocal connections to the VTA.  These data indicate that VTA 
GABA and glutamate neurons may have more dopamine-independent functions than previously 
recognized.   
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Introduction 
The ventral tegmental area (VTA) is involved in motivated, appetitive and reward-related 
behaviors (Fields et al., 2007).  Although the VTA is generally known as the source of 
dopaminergic (DA) projection neurons, it contains multiple cell types: DA (~60% of VTA cells 
in the rat), a subset of which express VGluT2 and release glutamate, GABAergic (~35% of cells) 
and purely glutamatergic neurons (~2-5% of cells, though some reports indicate a higher 
percentage), which are interspersed, but not equally distributed, among the subregions of the 
VTA (Yamaguchi et al., 2007; Nair-Roberts et al., 2008; Yamaguchi et al., 2011).  VTA DA 
neurons, including those also expressing VGluT2, project heavily to several limbic structures, 
including the nucleus accumbens (NAcc), amygdala, and prefrontal cortex (PFC).  In the rat, 
both GABAergic and glutamatergic neurons form local synapses in the VTA (Omelchenko and 
Sesack, 2009; Dobi et al., 2010) and project in parallel with the DA neurons to limbic regions 
(Swanson, 1982; Van Bockstaele and Pickel, 1995; Carr and Sesack, 2000a; Yamaguchi et al., 
2011).  Studies of VTA function have focused largely on the DA projections from the VTA, as 
these neurons are the most abundant VTA cell type.  In addition, drugs abused by humans 
increase DA levels in VTA projection areas (Di Chiara and Imperato, 1988).  However, early 
anatomical studies also identified substantial non-DA projections from the VTA to several brain 
regions (Swanson, 1982; Klitenick et al., 1992).  These studies combined retrograde tracing with 
immunohistochemical detection of tyrosine hydroxylase (TH), a dopamine-synthetic enzyme.  
Retrogradely-labeled neurons that were TH-negative were assumed to be GABAergic, but this 
has rarely been tested directly (Swanson, 1982; Klitenick et al., 1992; Carr and Sesack, 2000a).   
 Several lines of evidence indicate that VTA GABA neurons may have important 
functions independent from local inhibition of VTA DA neurons.  Although all drugs abused by 
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humans increase DA levels in VTA projection target regions, not all of these drugs act directly or 
exclusively on DA neurons.  Many drugs act on inhibitory GABAergic neurons, including 
alcohol, tetrahydrocannabinol (THC), opiates, benzodiazepines, and nicotine.  Descriptions of 
the mechanisms underlying the addictive properties of these drugs have focused on local 
GABAergic inhibition of VTA DA neurons (Johnson and North, 1992; Mansvelder and 
McGehee, 2002; Szabo et al., 2002; Tan et al., 2010; Tolu et al., 2013); however, DA-
independent effects of these drugs have also been proposed (Laviolette et al., 2002).  Recent 
studies using transgenic mice to monitor and drive VTA GABA neuron activity have shown that 
these neurons increase their firing rate in response to cues predicting reward and in response to 
aversive stimuli (Cohen et al., 2012; Tan et al., 2012). A deeper understanding of the VTA 
GABAergic system and its projections may therefore be critical for understanding the circuits 
involved in reward and in the addictive properties of these drugs of abuse. 
 The connectivity of VTA GABA neurons within the mesocorticolimbic circuitry provides 
further evidence of roles for VTA GABA neurons beyond local inhibition of VTA DA neurons.  
Ultrastructural studies have demonstrated striking and distinct specificity of excitatory PFC 
inputs onto VTA DA and GABA neurons, such that PFC inputs synapse onto GABA neurons 
projecting to NAcc and not to PFC, but onto DA neurons projecting to PFC and not NAcc (Carr 
and Sesack, 2000b).  A recent study using optogenetic methodology also suggested that VTA 
GABA neurons selectively innervate cholinergic interneurons in the striatum (Brown et al., 
2012).   
 To date, the majority of published studies on VTA projections have characterized the rat 
VTA.  The ability to identify and manipulate specific cell types using genetically modified mice 
has increased the use of mice for functional studies of the VTA and connected circuitry. 
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Knowledge of the mouse VTA and its projections has focused on dopaminergic circuits (Lammel 
et al., 2008; Lammel et al., 2011), but is not as well characterized as the rat.  In addition, recent 
reports have described both DA/VGluT2 neurons and non-DA, VGluT2-expressing neurons in 
the rodent VTA (Kawano et al., 2006; Yamaguchi et al., 2007; Hnasko et al., 2012).  Some of 
these putative glutamatergic neurons project from the VTA to PFC, NAcc, and other limbic 
structures (Yamaguchi et al., 2011; Gorelova et al., 2012; Hnasko et al., 2012), thus raising the 
possibility of more widespread VTA glutamatergic projections. Therefore, in this study we 
employed viral-vector mediated cell-specific anterograde tracing in combination with classical 
retrograde tracing in transgenic mice allowing for improved detection of GABAergic and 
glutamatergic neurons to provide more in depth characterization of non-dopaminergic 
projections from the mouse VTA.   
 
Materials and Methods 
Animals 
All animal studies were carried out in accordance with the standards and procedures for 
animal care and use established by the National Institutes of Health and were approved by the 
Yale University Animal Care and Use Committee. Three lines of transgenic mice targeting 
GABA neurons via glutamic acid decarboxylase (GAD) promoters were used in this study: 
GAD67-Cre (Ohtsuka et al., 2013), GAD65-IRES-Cre (Jackson Labs, Stock #010802) and 
GAD67-GFP knock-in mice (Tamamaki et al., 2003). In addition, VGluT2-IRES-Cre mice 
(Jackson Labs, Stock #016963) were used to identify VTA neurons expressing the vesicular 
glutamate transporter (VGluT2). In the transgenic lines, both males and females were used 
because no differences were observed between genders. The lines had been backcrossed onto 
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C57BL/6J mice for: GAD67-Cre, 4 generations; GAD65-IRES-Cre, 2-4 generations; GAD67-
GFP, 10 generations; VGluT2-IRES-Cre, 6 generations.   
 
Anterograde Tracing 
 GAD67-Cre and GAD65-IRES-Cre mice (12-16 weeks old) received VTA infusions of 
adeno-associated viruses (AAVs) driving Cre-dependent channelrhodopsin-fluorescent protein 
fusions (eYFP or mCherry; UNC Vector Core) by pressure injection in a stereotaxic frame (Kopf 
Instruments, Tujunga, CA) under isoflurane anesthesia (VetEquip, Pleasanton, CA).  Table 1 
describes the viruses used including their sources.  Coordinates for VTA infusions were, from 
bregma, AP: -2.9 to -3.1 mm; ML: +0.35 mm; DV: -4.65 mm.  0.2 – 0.5 µl of virus was infused 
unilaterally by pressure injection through pulled glass micropipettes with tips of 10-20 µm inner 
diameter.  Animals were kept warm until they had awakened and were returned to their home 
cages.  Survival times ranged from 21-28 days to ensure robust expression and trafficking of 
fluorescent proteins to distant terminals.  
 
Retrograde Tracing 
 For retrograde experiments, 50-100 nl of FluoroGold (FG, Fluorochrome, Inc., 
Englewood, Co; 1% in phosphate-buffered saline; PBS) or Red Retrobeads IX (beads, 
LumaFluor, Inc.) was infused by pressure injection through glass micropipettes (tips of 10-20 
µm inner diameter for FG, 50-60 µm inner diameter for beads) into several brain regions of 
GAD67-GFP knock-in mice (8-12 weeks old).  Coordinates for retrograde infusions were (all 
from bregma): NAcc shell (n=4); AP +1.8 – 2.0 mm, ML 0.55-0.6 mm, DV -4.75 mm; NAcc 
Core (n=3); AP +1.5 mm, ML +1.35 mm, DV -4.7 mm; lateral habenula (LHb; n=3): AP -1.9 
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mm, ML 0.6 mm, DV -3.2 mm; Amygdala (n=3): AP  -1.9 mm; ML 3.25 mm, DV -4.9 mm; 
ventral pallidum (VP; n=3): AP +0.7 mm, 0.55 mm, -5.0 mm; magnocellular preoptic nucleus 
(MCPO; n=2): AP +0.45 mm, ML 1.2 mm, DV -5.6 mm.  All infusions were unilateral.  
Following surgery, animals were returned to home cages to allow for transport of the tracer.  The 
survival time was seven days for FG and 21 days for beads.  
 For retrograde labeling of VGluT2+ neurons, VGluT2-IRES-Cre mice (8-10 weeks old, 
n=2 for each target region) received two intracranial infusions.  First mice received infusions of 
FG, as above, into one of the seven target regions, and subsequently all mice received infusions 
of AAV-DIO-Ef1a-mCherry into the VTA (coordinates the same as for anterograde tracers 
above).  Survival time was 14 days. 
 
Tissue processing and Immunohistochemistry 
For all tracing experiments, animals were injected with an overdose of chloral hydrate 
(15% in PBS) and transcardially perfused with ice-cold PBS (pH 7.4) followed by ice-cold 4% 
paraformaldehyde (PFA) in PBS (pH 7.4).  Brains were removed and post-fixed overnight in 4% 
PFA, then cryoprotected in 30% sucrose in PBS at 4º C until they sank.  For anterograde tracing, 
brains were sectioned from the rostral pole of cortex through the cerebellum in six series of 40 
µm thick sections on a sliding microtome (Leica Biosystems, Buffalo Grove, IL), resulting in 
series with sections 240 µm apart.  One entire series was stained, imaged and analyzed to 
determine anterograde projections.  For retrograde tracing, six series of 50 µm thick sections 
were taken through the injection site and 25 µm thick sections were cut through the VTA for 
analysis.  All of the sections containing VTA from a single series (5-6 sections) were stained and 
imaged to count retrogradely labeled cells. 
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 For immunohistochemical staining, free floating sections were washed 3 x 5 minutes in 
PBS at room temperature, then blocked for 1 hour in 10% Normal Donkey Serum (Jackson 
ImmunoResearch) with 0.3% Triton X-100 in PBS.  Sections were then transferred to primary 
antibody solutions (all antibodies diluted in PBS with 0.3% Triton X-100) and incubated 
overnight at 4º C (see Table 2 for sources and dilutions of primary antibodies).  In cases of 
double and triple labeling, sections were incubated in solutions containing multiple primary 
antibodies raised in different host species.  Sections stained for GAD67 were incubated in 
primary antibody at 4º C for three nights without Triton X-100, then any additional antibodies 
for double or triple labeling were added on the third day for overnight incubation.  After three 5 
minute washes in PBS at room temperature, sections were incubated in the appropriate 
combinations of secondary antibodies (AlexaFluor 405 Donkey anti-Sheep IgG, 1:500; DyLight 
488 Donkey Anti-Chicken IgY, 1:1000; AlexaFluor 555 Donkey anti-Rabbit, 1:1000; 
AlexaFluor 647 Donkey Anti-Goat, 1:500) for two hours at room temperature.  Sections were 
washed 3 times for 5 minutes in PBS, mounted on SuperFrost Plus Slides (Fisher Scientific) and 
coverslipped with FluoroMount G (Electron Microscopy Sciences, Hatfield, PA).  Incubations 
were carried out in light-protected conditions to preserve endogenous fluorescence of the tracers 
and virally-infected cells.  Secondary antibodies were obtained from Invitrogen or Jackson 
ImmunoResearch. 
 
Antibody Characterization 
Sheep anti-tyrosine hydroxylase, polyclonal 
According to the manufacturer (Millipore, Billerica MA; Cat. No. AB1542, RRID: AB_90755), 
the primary antibody was raised against native tyrosine hydroxylase (TH) from rat 
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pheochromocytoma cells.  Western blot analysis revealed on mouse brain lysate revealed one 
band of ~60 kDa.  The staining we observed in the ventral midbrain matches published reports of 
TH staining in the VTA and substantia nigra (Swanson, 1982). 
Rabbit anti-tyrosine hydroxylase, polyclonal 
According to the manufacturer (Millipore, Cat. No. AB152, RRID: AB_390204), the primary 
antibody was raised against denatured TH from rat pheochromocytoma cells (denatured by 
sodium dodecyl sulfate).  The manufacturer’s specification sheet indicates that western blot 
analysis labels a single band ~60-62 kDa.  The staining pattern we observed was restricted to 
cells with the classical dopaminergic localization in mouse brain (Swanson, 1982). 
Chicken anti-tyrosine hydroxylase, polyclonal 
According to the manufacturer (Thermo Scientific Pierce Antibodies, Cat. No. PA1-46351; 
RRID: AB_1091086), the primary antibody was raised against two separate peptide sequences, 
one from between amino acids 1-100 of the N terminus of mouse tyrosine 3-monooxygenase, 
and the second peptide from between amino acids 398-498 of the C-terminus of the same 
protein.  The staining pattern we observed was identical to staining with other anti-tyrosine 
hydroxylase antisera. 
Goat anti-glutamate decarboxylase 67 polyclonal 
According to the manufacturer (Abcam, Cambridge, MA; Cat. No. ab80589; RRID: 
AB_1640532), the primary antibody was raised against a synthetic peptide: C-
PDSPQRREKLHK, which corresponds to internal sequence amino acids 526-537 of human 
GAD67.  The manufacturer states that the antibody reacts with human, mouse and rat GAD67 
with no expected cross-reactivity with GAD65.  Western blot analysis of mouse brain lysate 
performed by the manufacturer selectively labels a single band at 67 kDa. 
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Chicken anti-green fluorescent protein polyclonal 
According to the manufacturer (Abcam, Cat. No. ab13970, RRID: AB_300798), this primary 
antibody was raised against recombinant full length GFP and recognizes enhanced GFP as well 
as all the fluorescent proteins by the jellyfish Aequorea victoria, including yellow fluorescent 
protein (YFP).  The manufacturer’s specification sheet indicates that western blot analysis of 
transgenic mouse spinal cord selectively labels a band at ~27 kDa.  In our hands, this antibody 
does not stain wild-type brain tissue which lacks GFP or YFP. 
Goat anti-choline acetyltransferase (ChAT) polyclonal 
According to the manufacturer (Millipore, Cat. No. AB144P, RRID: AB_2079751), the primary 
antibody was raised against human placental ChAT.  Western blot analysis of mouse brain lysate 
reveals one band at 70 kDa (manufacturer’s information).  In our experiments, staining was 
visible in cell bodies, dendrites and axons and was restricted to previously documented 
cholinergic regions (Ruggiero et al, 1990).  
Rabbit anti-NeuN polyclonal 
This antibody (Millipore, Cat. No. ABN78, RRID: AB_10807945) was raised against a GST-
tagged recombinant protein corresponding to mouse NeuN, and recognizes bands at 46 and 48 
kDa in western blot analysis of mouse brain nuclear extract (manufacturer’s information).  The 
antibody strongly labeled nuclei throughout the brain in our hands.  
Rabbit anti-dsRed polyclonal 
This antibody (Clontech, Mountain View, CA; Cat. No. 632496, RRID: AB_10013483) was 
raised against DsRed-Express, a variant of red fluorescent protein from Discosoma species, and 
recognizes DsRed and variants, including mCherry, and N- and C-terminal fusion proteins with 
these DsRed variants.  Western blot analysis of HEK293 cells stably expressing DsRed showed a 
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specific band of 30-38 kDa (manufacturer’s information).  In our hands, no staining was seen in 
animals lacking mCherry expression. 
Rabbit anti-vesicular GABA transporter (VGAT) polyclonal 
This antibody (Millipore, Cat. No. AB5062P, RRID: AB_2301998) was raised against a 17 
amino acid synthetic peptide corresponding to the last 17 amino acids at the carboxy terminal of 
rat VGAT (VHSLEGLIEAYRTNAED).  This antibody detected only one band of ~51 kDa in 
western blot analysis of mouse brain lysate (Wang and Sun, 2012).  The pattern of staining in our 
hands was similar to published reports (Wang and Sun, 2012).   
Rabbit anti-FluoroGold polyclonal 
This antibody (Fluorochrome, Inc., Denver CO, RRID: AB_2311977) was raised in rabbit 
against FluoroGold (hydroxystilbamidine) and did not stain tissue negative for FluoroGold in our 
hands.   
 
Imaging/Counting 
Sections from virally-infused brains for anterograde tracing were imaged on an 
epifluorescent Zeiss Axio Scope.  Mosaics of the hemisphere ipsilateral to the infusion site were 
taken with a 10x objective and excitation and emission filters for Alexa Fluor 488, 555 and 647 
signals.  Images were analyzed for presence of fluorescent fibers throughout the brain offline 
using Adobe Photoshop CS6. 
Sections from brains infused with retrograde tracers were imaged on an Olympus 
FV1000 laser-scanning confocal microscope equipped with the following lasers: 405 nm diode, 
488 Argon, 543 HeNe, and 633 HeNe.  VTA sections containing retrogradely labeled cells were 
identified under epifluorescence using excitation and emission filters for rhodamine and then 
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consecutive series of images with AF 405, 488, and 546 channels were taken with a 20x oil 
immersion objective (NA 0.85) at 1.64 µm steps along the z-axis, resulting in 10-12 optical 
sections.  Higher magnification images of individual neurons were taken with a 60x oil 
immersion objective (NA 1.42) or 100x objective (NA 1.40).  Consecutive images of VGAT 
stained tissue were taken with the 60x objective and a 2x or 2.5x digital zoom at 0.4 µm steps 
along the z-axis.   
For quantification of retrogradely labeled cells, two non-overlapping z-stacks were 
acquired to cover the entire medial to lateral extent of the VTA ipsilateral to tracer injection.  
Retrogradely labeled cells were counted from one single optical section from each z-stack. 
Optical sections for counting were selected randomly from each z-stack, but only if clearly 
defined cell bodies were visible in all the acquired channels. Sections containing the tissue 
surface were avoided.  Optical sections at the same focal plane were selected from the medial 
and lateral stacks of the same physical section.  Cells were counted using Adobe Photoshop CS6.  
The morphology and arrangement of DA neurons were used to identify the subnuclei of the VTA 
following published atlases (Paxinos et al., 2001).  The number of TH+, GFP+ (or GAD67+ for 
some sections), and retrogradely labeled cells (FG+ or beads+) was counted and marked in 
individual channels.  Then by combining the TH/retrograde or GFP/retrograde channels, the 
number of TH/retrograde, GFP/retrograde and TH(-)/ GFP(-)/retrograde cells was counted within 
each of the subnuclei of the VTA.  For each animal, the number of TH+, GFP+, retrogradely 
labeled, TH+/retrogradely labeled, GFP+/retrogradely labeled, and non-TH/non-
GFP/retrogradely labeled cells was totaled within each subnucleus (rostral linear nucleus (RLi), 
interfascicular nucleus (IF), parabrachial pigmented nucleus (PBP), paranigral nucleus (PN), 
caudal linear nucleus, CLi).  For VGluT2-IRES-Cre animals, cells were counted in the same 
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fashion, and the number of TH+, VGluT2+ (as marked by mCherry expression), and FG+ cells 
were counted and marked.  By combining the channels, the numbers of TH+/FG+, 
TH+/mCherry+/FG+, mCherry/FG+, and FG+ only labeled cells were counted and totaled within 
the VTA subnuclei. These totals were averaged across all the animals for each infusion region, 
and the percentages of retrogradely labeled cells that were also positive for TH or GFP (for 
GAD67-GFP mice), and for TH or mCherry (for VGluT2-IRES-Cre mice) or negative for both 
markers were calculated.   
Images taken to identify YFP+/VGAT+ terminals were analyzed in Olympus FV10-ASW 
3.0 Viewer software.  All figures were prepared using Image J (NIH, 
rsb.info.nih.gov/ij/index.html, RRID: nif-0000-30467) and Adobe Photoshop CS6 software.  For 
some images, brightness and contrast were adjusted, but no other manipulations were made. 
 
Results 
Viral injection of Cre-reporter constructs detects GABAergic cells in the VTA of GAD65-IRES-
Cre and GAD67-Cre mice 
 AAV-Ef1a-DIO-mCherry was infused into the VTA and used as a marker in Cre 
recombinase-expressing mice to identify GABAergic neurons. Infusion of AAV-Ef1a-DIO-
mCherry into the VTA of both GAD65-IRES-Cre and GAD67-Cre mice revealed mCherry 
expression in GABAergic neurons of the VTA (Fig 1A-H).  mCherry+ cells stained for GAD67, 
a GABA-synthetic enzyme, and lacked immunoreactivity for TH (Fig 1C, G, I), indicating a 
GABAergic, non-DA phenotype.  Qualitatively, GAD65-IRES-Cre mice appeared to have more 
mCherry labeling than did GAD67-Cre mice.  In both lines, some mCherry labeled cells did not 
show distinct GAD67 immunostaining, but were at the same level as the surrounding neuropil.  
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These cells may still be GABAergic, as immunohistochemical detection of GAD67 cell bodies in 
the VTA is difficult and underestimates the total GABAergic population (Olson and Nestler, 
2007; Nair-Roberts et al., 2008), and these cells were negative for TH (Fig 1D, H, I).  
GABAergic Cre-expressing cells were present in all subregions of the VTA (RLi, IF, PBP, PN, 
CLi). 
 
Anterograde Tracing 
 Twenty-five mice (15 GAD67-Cre, 10 GAD65-IRES-Cre) received infusions of adeno-
associated viruses (AAVs) driving Cre-dependent expression of fluorescent proteins into the 
VTA or surrounding areas.  Multiple viruses were used for cell-type specific tracing in order to 
avoid any virus-specific artifacts (viruses are described in Table 1).  All Cre-dependent marker 
viruses resulted in similar patterns of tracing and fluorescent protein expression.  Seven mice 
(four GAD65-IRES-Cre, three GAD67-Cre,) had infusions almost entirely limited to the VTA, 
and three GAD67-Cre mice had control infusions in surrounding areas that spared the VTA.  
These ten mice were chosen for further analysis.  Injection of AAV-Ef1a-DIO-ChR2-eYFP, 
AAV-Ef1a-DIO-SynB2-GFP, or AAV-Ef1a-DIO-ChR2-mCherry led to cell body labeling 
throughout the subnuclei of the VTA (Fig 1J, case S2).  Labeled cell bodies were found in the IF, 
RLi, CLi, PBP, and PN nuclei.  Figure 2 contains diagrams of the ventral midbrain 
demonstrating virally-labeled cell bodies from five mice (two GAD65-IRES-Cre, three GAD67-
Cre), focusing on those with virus confined mainly within the VTA and those with control 
infusions excluding the VTA (Cases GC 152, GC 116).   
 Viral expression restricted to VTA GABA neurons resulted in fluorescent labeling of 
fibers throughout much of the rostral-caudal extent of the brain.  The labeling patterns were 
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similar across all animals injected, with some slight differences attributable to viral spread.  
Cases S2, S3 (GAD65-IRES-Cre) and GC153 (GAD67-Cre) had infusions restricted almost 
entirely to the VTA and are described as representative cases of their respective lines. Cases S2 
and GC153 had a few labeled neurons in the interpeduncular nucleus (IPN), while S3 had a small 
number of labeled neurons in the medial posterior hypothalamus, periaqueductal grey and 
superior colliculus along the pipette track.   
In all animals, ascending fibers were concentrated along the medial forebrain bundle in 
the ventral portion of the forebrain.  The majority of fibers were ipsilateral to the infusion of 
virus, though in some cases contralateral projections were observed.  This may have been due to 
spread of the virus into both sides of the VTA, since labeled cell bodies were occasionally found 
bilaterally.  Images of several forebrain sections from case S2 are shown in Figure 3.  Labeled 
fibers were thin, often branched, and had bulging varicosities that are commonly accepted to be 
synaptic contacts (Figure 3D, inset).  In contrast to our hypothesis based on published work, only 
sparse labeling of PFC areas was visible (Fig 3A-C).  In some animals, few, if any, fibers were 
visible in medial pregenual cortical areas (data not shown).  The majority of labeled fibers in 
these cortical regions were concentrated in the deeper layers of cortex.  Similarly, innervation of 
the NAcc core and shell was also sparse (Fig 3D-F).  The fibers in NAcc core often were found 
near the medial portion of the core just below the tip of the ventricle.  Fibers in NAcc medial 
shell were spread throughout the structure.  The very few fibers visible in dorsal striatum were 
located along the lateral ventricle.  The major island of Calleja, located between NAcc medial 
shell and the lateral septum, contained labeled fibers in every animal with VTA injection (Fig 
3D-F; Fig 4A-B).   
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Dense fiber labeling was found in the VP and the lateral preoptic area (LPO) (Fig 3C-I).  
VTA efferent fibers were present throughout the rostral-caudal extent of the VP, but were more 
concentrated in the rostral regions.  In coronal sections, the rostral pallidum appears as patches 
separating the NAcc shell and olfactory tubercle. These patches show markedly less TH 
immunoreactivity than the surrounding ventral striatal regions, but often contained labeled fibers 
(Fig 4A-B).  Further caudal, fibers coursed continuously across the border of the dorsomedial 
pallidum and the LPO (Fig 3G-I).  Figure 4 shows line drawings of sections from a GAD65-
IRES-Cre animal (Case S3) and a GAD67-Cre animal (GC 153).  The projections of VTA 
neurons in the two lines displayed only slight differences.  At the level of VP, GAD67-Cre 
animals showed dense labeling in the ventral and lateral portions of pallidum, whereas in 
GAD65-IRES-Cre animals labeling was restricted to dorsomedial pallidum (Fig 4C-D). 
Moderate labeling was seen in several divisions of the bed nucleus of stria terminalis 
(BNST), including the medial ventral portion just beneath the anterior commissure (Fig 3J-L) 
and the lateral division, posterior part medial to the internal capsule (Fig 4E-F).  The caudal 
portion of the LPO also showed a dense population of VTA GABA fibers (Fig 3J-L).  Case S2 
showed labeling in the interstitial nucleus of the posterior limb of the anterior commissure 
(IPAC) (Fig. 3J-L).  GAD67-Cre animals had very little labeling in IPAC nuclei.   
GAD67-Cre mice showed extensive VTA GABAergic projections to the MCPO (Fig 4F).  
Sections from GAD65-IRES-Cre mice had strong labeling in the dorsal portion of the LPO, with 
some fibers also visible in the BNST divisions, just ventral to the anterior commissure.  Only a 
few fibers were visible in the horizontal limb of the diagonal band of Broca (HDB) and MCPO 
(Fig 3J-L; 4E-F).  These areas are sparsely innervated by dopaminergic fibers (Fig 3J-L).   
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VTA GABA neurons projected to the LHb in both lines.  GAD67-Cre fibers innervated 
the lateral ventrolateral portion of the LHb, whereas GAD65-IRES-Cre fibers consistently 
innervated the medial portion (Fig 4G-H; Fig 5A-C).  Very few TH+ fibers were present in LHb.  
In some cases, labeled fibers were seen in the mediodorsal thalamic nucleus.  VTA GABA fibers 
were also visible in the lateral hypothalamus and the amygdala. Among amygdalar nuclei in both 
GAD65-IRES-Cre and GAD67-Cre mice, labeled fibers preferentially innervated the central 
amygdala (Fig 4G-H; Fig 5D-F).  
 Labeled fibers were very concentrated at the injection sites in the VTA (Fig 4K-L).  No 
overlap was seen between labeled cells and TH immunoreactivity.  In many cases, the medial 
terminal nucleus of the accessory optic tract (MT), which borders the lateral portion of the VTA, 
was heavily labeled.  In these cases, fibers were seen in the nucleus of the optic tract (OT) in the 
dorsal midbrain.  Fibers were seen throughout the subnuclei of the VTA and reaching into the 
neighboring substantia nigra compacta and interpeduncular nucleus (IPN).  In some cases, 
GABAergic neuronal cell bodies of the IPN were clearly labeled by the virus.  YFP-labeled 
fibers in the IPN, therefore, could be from VTA or IPN GABA neurons.  The majority of labeled 
fibers in the IPN were distinct in appearance from fibers in the VTA or forebrain regions; they 
were dense mesh-like fibers surrounding labeled cell bodies, indicating that they may arise from 
IPN interneurons, rather than projection neurons.  It is still possible that the IPN could receive 
VTA GABA projections, as the IPN does contain TH+ fibers (data not shown).     
 In several cases, the ability to identify descending VTA GABAergic projections was 
complicated by labeling of cell bodies in the IPN, which projects heavily to brainstem nuclei.  
Nevertheless, some areas of the dorsal midbrain and brainstem displayed consistent labeling 
across animals, regardless of the extent of IPN labeling (Fig 4M-N).  In some cases, cell bodies 
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were labeled in the A8 dopaminergic nucleus, the retrorubral field (RRF).  In most cases, even 
with no cell bodies visible, fibers were visible in RRF, but these were characteristic of fibers of 
passage coursing dorsally.  Moderate anterograde labeling was seen in the ventral and lateral 
portions of the periaqueductal gray (PAG, Fig 4M-P).  Case S2 showed modest labeling in the 
median raphe (MnR), including the paramedian portion.  Case GC153, which had few labeled 
cell bodies in IPN, also had labeled fibers in MnR, suggesting a minor VTA GABA projection.   
 The dorsal raphe contained labeled fibers, particularly in the dorsal, ventral and lateral 
parts, and in the raphe cap (Fig 4M-P; Fig 5J-L).  Some of the fibers in lateral dorsal raphe 
originated from GABA neurons in lateral PBP, RRF and CLi.  Anterograde labeling was visible 
in the pedunculopontine tegmental nucleus (PPTg), but most of the labeling was characteristic of 
fibers of passage.  All of the analyzed GAD65-IRES-Cre animals showed sparse, but consistent, 
labeling of the ipsilateral external cortex of the interior commissure (ECIC).  GAD67-Cre mice 
showed labeling in the superior colliculus, both in the superficial and intermediate gray layers.  
In both GAD67 and GAD65-IRES-Cre lines, the laterodorsal tegmental nucleus (LDTg) 
contained labeled fibers (Fig 4O-P; Fig 5J-L).  Sparse labeling was also seen in the locus 
coeruleus (LC) in both lines.  A few fibers were observed in the ipsilateral lateral and medial 
parabrachial nuclei (LPBC, MPB).  In the ventral brainstem, labeling was seen in the rostral 
periolivary region (RPO) in some animals.  This could have resulted from labeled cells in the red 
nucleus, as a control infusion (GC 152) centered in red nucleus that spared VTA resulted in 
heavy projections to RPO and surrounding areas (data not shown).   
 Table 3 shows the relative density of projections throughout the brain for several cases 
with virus mainly restricted to the VTA.  The results were largely consistent between cases, 
though some additional differences between GAD65-IRES-Cre and GAD67-Cre mice were 
Page 18 of 70
John Wiley & Sons
Journal of Comparative Neurology
 19
noted.  For example, GAD67-Cre mice showed light to moderate labeling in areas lateral to the 
NAcc (piriform cortex, claustrum, endopiriform nucleus) while GAD65-IRES-Cre mice did not.   
 Analysis of control infusions of AAV-DIO-Ef1a-ChR2-eYFP (GC 116) or AAV-DIO-
Ef1a-ChR2-mCherry (Cases GC 152 and 156) into regions neighboring the VTA revealed 
patterns of labeled fibers distinct from VTA injections.  Case 116 was centered in the IPN, Case 
152 was centered in the red nucleus, dorsal to the VTA, and Case 156 was centered in the rostral 
periaqueductal grey and posterior hypothalamus anterior to the VTA.  In contrast to VTA 
injections, very few, if any, labeled fibers were visible in VP, NAcc, MCPO, LHb, or dorsal 
raphe.  Cases 152 and 156 resulted in extensive labeling in the thalamus and dorsal midbrain, and 
Case 116 resulted in labeled fibers throughout the median raphe and anterior tegmental nucleus 
(data not shown).  
 Brown et al (2012) recently reported that VTA GABA neurons projecting to the NAcc 
shell selectively target cholinergic interneurons.  To identify possible postsynaptic target cells of 
VTA GABA neurons, we stained for choline acetyltransferase (ChAT), a marker of cholinergic 
cells, as well as NeuN to visualize all the neurons.  We observed labeled fibers that encapsulated 
ChAT+ cell bodies (Fig 6A-C) in both the NAcc shell and core.  These fibers had several 
varicosities that apposed the soma and dendrites of the ChAT+ neurons.  Triple labeling for YFP, 
ChAT and NeuN showed that labeled fibers also surrounded ChAT-negative cells (Fig 6C).   
 To verify that YFP+ labeled fibers showed evidence of inhibitory neurotransmission, we 
performed double staining for YFP and the vesicular GABA transporter (VGAT), the protein that 
packages GABA into synaptic vesicles at inhibitory terminals.  A subset of YFP+ varicosities 
showed clear co-labeling with VGAT in the LHb (Fig 6D), NAcc shell, major island of Calleja, 
VP, amygdala, and VTA.  This demonstrates that VTA GABA neuron fibers in the areas 
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mentioned above contain GABAergic varicosities, suggesting the presence of synaptic 
connections. 
 
Retrograde Tracing 
Retrograde labeling experiments were performed in a subset of projection target regions 
to confirm the specificity of anterograde labeling and to characterize the localization of GABA 
projection neurons within the VTA.  Retrograde tracers (Red Retrobeads IX or Fluorogold) were 
infused into the NAcc shell, NAcc core, PFC, amygdala, LHb, VP and MCPO of GAD67-GFP 
knock-in mice and VGluT2-IRES-Cre mice.  Injections into VP in most cases included adjacent 
regions of the bed nucleus of the stria terminalis (BNST) and injections into MCPO often spread 
into the olfactory tubercle (OT), and are abbreviated as VP/BNST and MCPO/OT, respectively. 
GAD67-GFP mice were used to facilitate identification of GABAergic neurons within the VTA 
after pilot immunohistochemistry experiments marked only a small subset of GABAergic cell 
bodies within the VTA, as others have reported (Fig 7A-D; Olson and Nestler, 2007), and 
VGluT2-IRES-Cre mice were used to identify glutamate neurons.  In some cases, Fluorogold 
(FG) occasionally diffused more widely from the infusion site than the Retrobeads.  FG 
injections into MCPO/OT and VP/BNST resulted in many more retrogradely labeled neurons in 
the VTA than did the beads; however, the percentages of TH, GFP, VGluT2 or non-labeled cells 
were similar across tracers, so the data were analyzed and combined across experiments (Fig 7J-
K).   
Figure 8 shows representative infusion sites from the seven tested regions.  Retrograde 
infusions in NAcc shell, NAcc core, LHb, amygdala, VP/BNST and MCPO/OT resulted in 
labeled cells throughout the VTA (Fig 7E-H).  Double immunohistochemical staining for GFP 
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and TH revealed that projections to various target regions differ in neurotransmitter content and 
in location of origin within the VTA.  As no co-localization of GFP and TH was observed in any 
experiment, retrogradely labeled cells in GAD67-GFP mice were classified as TH+, GFP+, or 
TH(-)/GFP(-) (Fig 7E-I).  The locations of retrogradely-labeled/GFP neurons from a 
representative case for each infusion site are graphed in Figure 9.   
Overall, the majority of GABAergic projections labeled by retrograde tracing originated 
from the PBP and paranigral PN subnuclei.  The RLi and IF had few detectable GABAergic 
projection cells by retrograde tracing, but had numerous TH(-)/GFP(-)/retrogradely labeled cells.  
Among the projection target regions, the projection to LHb had the highest GABAergic 
component, followed by PFC, VP, and amygdala.  NAcc core infusions resulted in very few 
GABAergic retrogradely labeled cells.  Unexpectedly, the majority of TH(-)/retrogradely-labeled 
cells were also GFP(-), especially in the RLi and IF, and in the projection to the LHb.  The 
percentages of retrogradely labeled cells by neurotransmitter phenotype are graphed for each 
VTA subnucleus and tracer infusion site in the left hand column of Figure 10.   
To identify the neurochemical identity of non-dopaminergic, non-GFP/retrogradely 
labeled cells, we performed another set of retrograde tracing studies in VGluT2-IRES-Cre mice.  
These mice received two infusions: FG into a target region and AAV-DIO-Ef1a-mCherry into 
the VTA to visualize VGluT2+ cells.  VGluT2+ cells were found throughout the VTA, but were 
concentrated in the medial nuclei (RLi, IF, CLi), and the medial portions of PBP and PN.  There 
was substantial overlap of VGluT2 with TH.  51% of the VTA TH+ neurons co-expressed 
VGluT2 (55% in RLi, 67% in IF, 30% in PBP, 66% in PN, 39% in CLi), though our methods 
were not designed to quantify and estimate the total TH/VGluT2 population rigorously.  
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Conversely, only 33% of VGluT2+ cells expressed TH (7% in RLi, 18% in IF, 32% in PBP, 54% 
in PN, and 56% in CLi).   
Immunohistochemical detection of TH and FG, along with mCherry expression 
(VGluT2+), revealed the following classes of retrogradely labeled cells: FG/TH only, 
FG/TH/VGluT2, FG/VGluT2 only (glutamatergic), and FG/TH(-)/VGluT2(-) (putative 
GABAergic).  Examples of neurons in these classes are demonstrated in Figure 11.  The 
percentages of retrogradely labeled cells by neurotransmitter phenotype are graphed according to 
VTA subnucleus and tracer infusion site in the right hand column of Figure 10.  Table 4 contains 
the percentages of FG+ cells in each of the four classes by VTA subnucleus and infusion region.  
These experiments revealed that the vast majority of DA neurons projecting to the amygdala 
from all regions of the VTA also express VGluT2.  The majority of the DA projection neurons in 
the PN also express VGluT2.  This was true for all the target regions tested.  In addition to a 
substantial portion of TH+ projection neurons that express VGluT2, the VTA contains VGluT2 
only neurons that project to each area examined.  FG/VGluT2 cells were concentrated in the 
medial aspects of the VTA, and comprised the vast majority of the projections of RLi and IF to 
VP/BNST and MCPO/OT in particular.   
Comparison of the retrogradely labeled cells between experiments in GAD67-GFP and 
VGluT2-IRES-Cre mice revealed strikingly similar results for the PBP, PN, and CLi subnuclei 
of the VTA. Retrogradely labeled cells in the RLi and IF subnuclei showed more variability 
between the two mouse lines, but the differences were primarily in animals with few retrogradely 
labeled cells in these areas. These data indicate that a substantial proportion of the non-
dopaminergic projections from the VTA express VGluT2 and are likely glutamatergic. 
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Figure 12 shows the locations of FG/VGluT2-only cells from a representative case from 
each tracer infusion site.  These cells were concentrated in the dorsal and medial aspects of the 
VTA, and were occasionally found in the lateral and ventral regions. In the mouse VTA, these 
medial areas have fewer dopaminergic cells than the more lateral aspects.  This is in contrast to 
the distribution of VTA GABA projection neurons, which were primarily located in the ventral 
and lateral aspects of the VTA.  In most of the retrograde tracing experiments, a small percentage 
of the total VTA cells were labeled with tracer.  Table 5 shows the percentage of the counted 
VTA cells of each neurotransmitter phenotype that were retrogradely labeled.    
   
Discussion 
In this study we demonstrate that GABAergic and glutamatergic neurons in the mouse 
VTA project widely to sites throughout the forebrain and brainstem.  VTA GABA neurons 
project primarily to limbic structures other than PFC and NAcc, including the LPO, MCPO, 
BNST, central amygdala, LHb, and VP, and dorsal raphe.  These projection neurons originate 
from all VTA subnuclei, but are concentrated in the lateral VTA.  In addition, retrograde tracing 
data indicate that the mouse VTA also contains substantial populations of both TH/VGluT2 and 
VGluT2-only projection neurons.  Many of the TH neurons, especially in medial VTA, express 
VGluT2.  TH/VGluT2 neurons project to several forebrain regions, and make up the majority of 
dopaminergic projections from the paranigral nucleus.  VGluT2-only projection neurons are 
concentrated in the dorsal and medial regions of the VTA and project heavily to LHb, VP/BNST, 
and MCPO/OT.  This indicates that the glutamatergic output of the mouse VTA may be more 
extensive than previously appreciated.  Some of these structures receive only minimal 
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dopaminergic innervation, indicating that VTA GABA and glutamate projections form circuits 
distinct from those of neighboring DA neurons.   
 
Technical Considerations 
A number of methodological issues should be considered as potential caveats for the 
current study.  Tracer uptake by damaged fibers of passage could result in false positive labeling, 
but we feel this does not confound our results for several reasons.  Virally-labeled cell bodies 
were restricted to injection sites, indicating that viruses were taken up by cell bodies rather than 
terminals or fibers of passage.  Our main conclusions arise from data confirmed by both 
retrograde and anterograde experiments, and as these were strongly consistent with each other 
and with the literature, we conclude that VTA GABA neurons do indeed make the observed 
projections.  We also observe VGAT+ varicosities or terminals within the regions infused with 
retrograde tracers, suggestive of synaptic connections in these areas.  It remains possible, 
however, that some retrogradely labeled cells may have resulted from tracer uptake by damaged 
fibers.   
The virus used for anterograde tracing could have spread to adjacent areas such as the 
rostromedial tegmental nucleus (RMTg), which has been shown in the rat to have overlapping 
projections with our data (Jhou et al., 2009).  In some cases cell bodies in the RMTg were 
infected with virus (Figure 2).  However, this was a very small percentage of the total population 
of labeled cells, and in our hands very few cells in the RMTg were labeled with retrograde 
tracers, whereas GABAergic cells were found throughout the VTA.   
 Another potential concern is the sensitivity of our methods to detect GABAergic or 
glutamatergic cell bodies in the VTA.  Our pilot studies and other labs have shown that 
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immunohistochemical detection with GAD or GABA antisera in the VTA does not reliably mark 
cell bodies (Olson and Nestler, 2007; Nair-Roberts et al., 2008).  Other approaches to label 
GABAergic and glutamatergic cell bodies include the use of transgenic mice or in situ 
hybridization (ISH) to label GAD or VGluT2 mRNA.  We used GAD67-GFP and VGluT2-
IRES-Cre mice to facilitate detection of multiple other markers in the same tissue (TH and 
retrograde tracers), which may not have been possible with ISH.  In GAD67-GFP mice, we 
observe many retrogradely labeled cells which lack both TH and GFP.  This led us to conduct 
parallel experiments in VGluT2-IRES-Cre mice to label glutamatergic neurons.  These 
experiments reveal retrogradely labeled cells which lacked TH and VGluT2.  In both mouse 
lines, some of these neurons may be false negatives.  Importantly, the proportions of retrogradely 
labeled neurons classified as dopaminergic, GABAergic and glutamatergic are similar between 
the two lines, indicating that possible false negatives only minimally contribute to our data.   
We view the possibility of false negative DA projection neurons as unlikely because the 
percentage of retrogradely labeled cells positive for TH in our experiments either matched or 
exceeded those reported the literature, and TH labeling was very consistent across experiments.  
The GAD67-GFP knock-in line may not label all GABAergic neurons in the VTA.  Slight 
differences in the pattern of Cre-expressing cells in the GAD67-Cre and GAD65-IRES-Cre 
mouse lines and published ISH studies of GAD isoforms indicate that the two enzymes may be 
expressed in somewhat distinct cellular populations (Esclapez et al., 1993).  GAD65-expressing 
neurons may therefore account for a proportion of the retrogradely-labeled TH(-)/GFP(-) neurons 
in GAD67-GFP mice.  The results of our retrograde studies in VGluT2-IRES-Cre mice indicate 
that many of these cells express VGluT2. As we did not label for TH, GAD and VGluT2 in the 
same tissue, it is possible that our data contain false negatives, but the degree of similarity 
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between the experiments in the two lines indicates that this cannot entirely account for the 
observed retrogradely-labeled only neurons.   
For labeling of putative glutamatergic neurons we infused a virus expressing Cre-
dependent mCherry in VGluT2-IRES-Cre knock-in mice.  Cre expression in these mice is 
restricted to areas containing VGluT2 mRNA (Vong et al., 2011).  Our data reveal VGluT2 
labeling very consistent with that described by Yamaguchi et al (2011), with a strong 
mediolateral gradient of expression and substantial overlap with TH immunoreactivity.  The 
large number of cells labeled by the virus indicates we did not likely have many false negative 
cells.  Conversely, there may be cells expressing Cre recombinase that may be of another 
neurotransmitter phenotype.  However, we believe that these do not make up a large portion of 
our data for several reasons.  First, as noted above, we find very high similarity between the 
results of our retrograde studies using two different transgenic lines to label separate but 
complementary populations of VTA neurons.  Second, we find very similar ratios of neurons 
projecting to the NAcc as found in the Yamaguchi study.  Third, our retrograde studies are 
consistent with projections recently described using viral-vector mediated anterograde tracing in 
a different line of VGluT2-Cre mice (Hnasko et al., 2012). The high degree of similarity between 
our results and studies using other methods, including more traditional ISH labeling of VGluT2 
mRNA, suggests that VGluT2-IRES-Cre mice reliably label VGluT2-expressing cells in the 
VTA. 
 
Comparison to Literature 
 
We describe four classes of VTA projection neurons: TH, TH/VGluT2, GAD, and 
VGluT2-only expressing cells.  The DAergic projections in this study are largely consistent with 
prior work in rat (Swanson, 1982; Klitenick et al., 1992; Del-Fava et al., 2007).  We find higher 
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ratios of DA neurons in the IF projections to NAcc, amygdala and PFC than has been published.  
The DA content of the VTA-LHb projection we report is very similar to that described by 
Swanson, but less than what has been reported in more recent work (Li et al., 1993; Gruber et al., 
2007).  We also find a higher percentage of DA neurons in the mesocortical projection from all 
regions of VTA than has been shown previously in rat studies.  These discrepancies could be due 
to species differences between rat and mouse in DA neuron density or projections, or to 
differential placement of the tracer between studies.  
Our experiments confirm and extend recent work describing VGluT2-expressing 
projection neurons, which includes both TH/VGluT2 and VGluT2-only neurons (Hur and 
Zaborszky, 2005; Lavin et al., 2005; Yamaguchi et al., 2011; Gorelova et al., 2012; Hnasko et 
al., 2012).  The majority of dopaminergic projections from the paranigral nucleus and nearly all 
of the dopaminergic neurons projecting to amygdala express VGluT2.  Evidence from several 
groups indicates that VTA TH/VGluT2 neurons projecting to NAcc are capable of releasing both 
DA and glutamate (Chuhma et al., 2009; Hnasko et al., 2010; Stuber et al., 2010; Tecuapetla et 
al., 2010).  Our data indicate that TH/VGluT2 neurons also project to the amygdala, VP/BNST 
and MCPO, raising the possibility that co-release of DA and glutamate may occur in these areas.  
Further studies are necessary to determine the extent and function of co-release in areas other 
than the striatum. 
 Previous studies have identified GABAergic projections to the NAcc in rats and mice, to 
LHb in mice (Van Bockstaele and Pickel, 1995; Brown et al., 2012; van Zessen et al., 2012; 
Stamatakis et al., 2013), and to PFC, dorsal raphe and VP in rat (Steffensen et al., 1998; 
Gervasoni et al., 2000; Carr and Sesack, 2000a; Mitrovic and Napier, 2002; Kirouac et al., 2004).  
VTA glutamate neurons have been shown to project to NAcc and PFC in rats and mice, and to 
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LHb, amygdala, and VP in mice (Pirot et al., 1992; Yamaguchi et al., 2011; Gorelova et al., 
2012; Hnasko et al., 2012). Our data identify more widespread projections to limbic structures 
for both VTA GABAergic and glutamatergic neurons.  The GABAergic projections to MCPO, 
BNST, LPO, and LH identified here have not been described previously.  Unexpectedly, we find 
that the majority of non-DA VTA projections in mouse express VGluT2 rather than GAD.  We 
confirm that VTA glutamate neurons project to LHb, PFC and NAcc shell and core, and 
demonstrate that these neurons also project to the amygdala, MCPO/OT, and VP/BNST.  Both 
VTA GABA and glutamatergic neurons make local connections onto both DA and non-DA 
neurons (Omelchenko and Sesack, 2009; Dobi et al., 2010), but it is not known if these cells also 
send collaterals outside of the VTA.  While GABA neurons comprise 30-35% of the total VTA 
population, they make up a much smaller percentage of the retrogradely-labeled neurons in this 
study, which may indicate that a substantial proportion are local interneurons.  For both GABA 
and glutamate neurons, however, it remains unclear whether there are distinct classes of local 
interneurons and projection neurons.  
Our data revealed overall strong similarity between projections using GAD67-Cre and 
GAD65-IRES-Cre mice, though there were some interesting differences.  At the level of the 
VTA, GAD65-IRES-Cre mice appear to have more Cre-expressing cells than GAD67-Cre mice, 
though this was not quantified.  It is unclear why this may be, but it could be due to differences 
in GAD isoform expression, as has been suggested in some brain regions (Escalpez et al., 1993), 
or to differences in the method for generation of the two mouse lines.  The GAD65-IRES-Cre 
line is a knock-in mouse, whereas the GAD67-Cre line is a BAC transgenic.  Potential functional 
implications of these different projections would depend on whether differential Cre expression 
is truly reflective of differential GAD isoform expression. 
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Comparison of the GABAergic and glutamatergic projections we observed with known 
VTA afferent regions reveals that all regions that receive GABAergic and glutamatergic input 
from the VTA also project back to the VTA (Geisler and Zahm, 2005; Watabe-Uchida et al., 
2012).  The work of Zahm and colleagues has documented that many of these areas are also 
interconnected (Geisler and Zahm, 2005).  Thus the VTA GABAergic and glutamatergic 
projections are part of these larger networks, of which only some are shared with the DA 
projection system.  Interestingly, VP, LPO, BNST and LH, which we show receive dense VTA 
GABA input with relatively less DA input than NAcc, are major sources of afferent input to the 
VTA (Geisler and Zahm, 2005).  Thus VTA non-DA neurons are positioned to provide 
inhibitory or disinhibitory feedback to the VTA through both local and long-range connections. 
  
Functional Implications 
VTA GABA neurons have been implicated in brain stimulation, reward processing, and 
drug reward, but these studies have largely focused on local intra-VTA mechanisms (Johnson 
and North, 1992; Klink et al., 2001; Mansvelder and McGehee, 2002; Szabo et al., 2002; Lassen 
et al., 2007; Cohen et al., 2012; van Zessen et al., 2012; Tolu et al., 2013).  Early descriptions of 
VTA GABAergic projections suggested they might have roles beyond local inhibition (Van 
Bockstaele and Pickel, 1995; Steffensen et al., 1998; Carr and Sesack, 2000a; 2000b).  Our data 
support the possibility of an expanded role of VTA non-DA neurons in reward processing.  We 
demonstrate non-DA input from the VTA to several regions which support intracranial self-
stimulation, intracranial self-administration or place conditioning, including the LPO, LH, VP, 
and raphe nuclei (Wise, 1996; McBride et al., 1999).  The DA projection from VTA to NAcc is 
critical for reward-related behaviors (Ikemoto, 2010); interestingly, the NAcc projects heavily to 
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the VP.  Thus, VTA GABA and glutamate neurons projecting to VP could influence reward 
processing downstream of VTA-NAcc DA projections.   
Our results indicate that drugs of abuse with primary actions on non-DA neurons may 
influence VTA GABA, and potentially glutamate, circuits independent of DA neurons.  
Interestingly, intracranial administration of nicotine into the VTA can have DA-independent 
behavioral effects (Laviolette and van der Kooy, 2003; Tolu et al., 2013).  The GABAergic and 
glutamatergic circuits from the VTA to downstream limbic regions may be responsible for such 
effects. VTA GABA and glutamate neurons are therefore positioned to influence both local and 
network processing of rewarding and reinforcing stimuli (Ikemoto, 2010).   
Little is known about what stimuli activate the glutamatergic neurons of the VTA or what 
functions they may serve, but recent work using optogenetic methods has examined GABAergic 
projections to the striatum.  Brown and colleagues (2012) showed that activation of VTA GABA 
projections to striatum inhibited cholinergic interneuron activity and enhanced associative 
learning.  Another recent study showed that acute activation of VTA GABA neurons reduced 
reward consumption (van Zessen et al., 2012).  This effect was seen with stimulation of cell 
bodies in the VTA, but not with stimulation of GABAergic terminals in NAcc.  While this may 
be due to local inhibition of DA neurons (Omelchenko and Sesack, 2009; Tan et al., 2012; 
Bocklisch et al., 2013), GABAergic projections to regions outside the NAcc may also account 
for this effect.  Our data indicate that the VTA-NAcc projection is one of the more minor VTA 
GABAergic projections, so it is plausible that other projections also have behavioral 
significance.   
Recent studies in mouse have demonstrated that VTA GABA neurons are activated by 
aversive stimuli and by reward-predicting cues (Cohen et al., 2012; Tan et al., 2012).  Such 
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stimuli could lead to alterations in VTA DA neuron firing by direct local inhibition as well as 
indirectly via LHb, NAcc, or VP projections back to VTA.  Interestingly, GABA neurons 
projecting to LHb would have effects opposite that of local inhibition, as the LHb inhibits DA 
neuron firing via the RMTg (Jhou et al., 2009; Hong et al., 2011).  Indeed, release of GABA 
from VTA-LHb projections results in reward-related behaviors (Stamatakis et al., 2013), whereas 
activation of GABAergic cell bodies in the VTA can drive aversion (Tan et al., 2012).  As 
mentioned, it is unclear if VTA GABAergic or glutamatergic projections send local collaterals.  
Our data suggest that VTA GABA and glutamate projection neurons can convey these aversive 
and reward-related signals independently to several downstream limbic regions involved in 
appetitive and motivational responses.   
 
Conclusions 
We demonstrate that VTA GABA and glutamate neurons project to several forebrain and 
brainstem structures, many of which do not receive major dopaminergic input.  Several of these 
structures, in turn, are connected with the VTA and with each other, indicating that VTA GABA 
and glutamate neurons are part of larger networks that have been implicated in reward 
processing.  Future studies genetically targeting VTA GABA or glutamate neurons should take 
into account these projections as well as local connections.   
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Figure Legends  
 
Table of Abbreviations Used in Figures 
 
ac anterior commissure LSV lateral septal nucleus, ventral part 
BLA basolateral amygdalar nucleus MCPO magnocellular preoptic nucleus 
BNST bed nucleus of the stria terminalis MDM mediodorsal thalamic nucleus, medial part 
CeA central amygdalar nucleus mfb medial forebrain bundle 
ChAT choline acetyltransferase MHb medial habenula 
ChR2-YFP channelrhodopsin fused to yellow fluorescent protein MnR median raphe nucleus 
Cli caudal linear nucleus MS medial septum 
DpMe deep mesencephalic nucleus NAcc nucleus accumbens 
DR dorsal raphe nucleus PAG periaqueductal gray 
DRC dorsal raphe nucleus, caudal part PBP parabrachial pigmented nucleus 
ECIC external cortex of the inferior colliculus PFC prefrontal cortex 
FG fluorogold PMnR paramedian raphe nucleus 
fr fasciculus retroflexus PN paranigral nucleus 
GAD65 glutamic acid decarboxylase, 65 kDa isoform PnC pontine reticular nucleus, caudal part 
GAD67 glutamic acid decarboxylase, 67 kDa isoform PPTg pedunculopontine tegmental nucleus 
GFP green fluorescent protein PreL prelimbic cortex 
HDB horizontal limb of the diagonal band of Broca PV paraventricular thalamic nucleus 
ICjM islands of Calleja, major island RC raphe cap 
IF interfascicular nucleus Rli rostral linear nucleus 
IL infralimbic cortex RN red nucleus 
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IMD intermediodorsal thalamic nucleus SI substantia innomata 
IPAC interstitial nucleus of the posterior limb of the anterior commissure SNc substantia nigra, pars compacta 
IPN interpeduncular nucleus SNr substantia nigra, pars reticulata 
LDTg laterodorsal tegmental nucleus TH tyrosine hydroxylase 
LH lateral hypothalamus VGAT vesicular GABA transporter 
LHb lateral habenula VP ventral pallidum 
LPO lateral preoptic area VTA ventral tegmental area 
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Figure 1. GAD-Cre animals allow for cell-specific anterograde tracing.  Infusion of AAV-Ef1a-
DIO-mCherry permits visualization of Cre-expressing cells in the ventral tegmental area (VTA; 
panels A, E).  Many Cre-expressing cells in GAD67-Cre (A-D) and GAD65-IRES-Cre mice (E-
H) clearly stain for GAD67 and lack tyrosine hydroxylase, a marker of dopamine neurons (white 
arrows).  GABAergic Cre+ cells are present throughout the subregions of the VTA (Panel I).  J) 
An example infusion site for anterograde tracing demonstrating labeling centered in the VTA 
(Case S2, used for Figures 3 and 5) Scale bars in panels D, H, I = 50 µm, in panel J = 200 µm. 
 
Figure 2. Injection sites for five cases (three restricted almost entirely to VTA, two control 
infusions) of viral infusion into GAD-Cre animals for anterograde tracing.  Coronal drawings 
from rostral (top) to caudal VTA (bottom) depict the spread of virus (as detected by transduced 
cell bodies). Each dot represents an eYFP-expressing cell body transduced by the virus.  Cases 
GC 152, 153, and 116 are GAD67-Cre mice, and Cases S2 and S3 are GAD65-IRES-Cre mice.  
In case GC 152, the infusion was restricted to the red nucleus, dorsal to the VTA, and in case GC 
116 the infusion was centered in the interpeduncular nucleus, ventral to the VTA.   
 
Figure 3. Panels showing anterograde labeled GABAergic fibers from case S2, which had an 
infusion of virus driving channelrhodopsin-eYFP, stained for eYFP (green) and TH (magenta).  
Panels A, D, G, and J show diagrams of forebrain sections containing labeled fibers.  Black 
boxes indicate the regions shown in B, E, H, and K.  Panels C, F, I, and L differ from B, D, F, 
and H only in the addition of the TH channel to delineate brain regions.  Inset in Panel E shows 
the varicose nature of the fibers in surrounding the island of Calleja (scale bar = 10 µm).  Note 
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the largely non-overlapping patterns of GABAergic fibers and TH labeling.  Scale bars in in C, 
F, I, L = 100 µm. 
 
Figure 4. Coronal diagrams of line drawings of labeled fibers in representative cases from 
similar levels in both GAD65-IRES-Cre mice (Case S3; A, C, E, G, I, K, M, O) and GAD67-Cre 
mice (Case GC 153; B, D, F, H, J, L, N, P).   
 
Figure 5. Panels showing images from more caudal areas of case S2 stained for 
channelrhodopsin-eYFP (green), TH (magenta) and ChAT (blue).  Panels B, E, H, and K are 
enlargements of the areas outlined in A, D, G and J, respectively.  Scale bars = 100 µm.   
 
Figure 6. VTA GABA neurons surround cholinergic and non-cholinergic neurons.  A) Low 
magnification projection image depicting GABAergic fibers apposing cholinergic cellular 
profiles (white arrowheads) and non-cholinergic regions (white arrows) in NAcc core (from case 
S2).  B) High magnification projection image of outlined region in panel A.  Note how the 
labeled fibers follow the proximal dendrites and contain several varicosities that appose the cell 
body and dendrites of cholinergic neurons.  C) Triple labeling in NAcc shell for fibers, 
cholinergic cells and NeuN to reveal all neuronal nuclei suggest that GABA fibers may make 
similar appositions and encapsulations around non-cholinergic cells (white arrow, see white 
arrows in panel A).  D) Co-localization of YFP+ varicosities and boutons with immunolabeling 
of the vesicular GABA transporter, which is localized to inhibitory synapses, indicates that these 
fibers are indeed GABAergic and make inhibitory connections.  This image is from the lateral 
habenula (LHb) of case S2. Similar co-labeling with VGAT is seen in LHb, CeA, VP, NAcc and 
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VTA of both GAD67-Cre and GAD65-IRES-Cre mice.  Orthogonal views are of the bouton 
nearest the scale bar in lower right.  Scale bars in A = 50 µm; B, C = 10 µm; D = 5 µm. 
 
Figure 7. Retrograde tracing in GAD67-GFP knock-in mice.  A-D) GFP+ cells in the VTA show 
immunohistochemical markers of GABA neurons (white arrows).  Most, but not all GFP+ 
neurons (black arrowheads), clearly stain for GAD67 and lack TH immunoreactivity.  Some are 
at the same level as surrounding neuropil.  E-H) Injection of FluoroGold (FG) into the 
magnocellular preoptic nucleus revealed three classes of VTA projections: FG/TH 
(dopaminergic), FG/GFP (white arrowheads, GABAergic) and FG+ only (black arrows, TH- and 
GFP-; non-DA, non-GABA).  I) Injections of Red Retrobeads gave similar results (white 
arrowhead shows a GFP+/retrogradely labeled cell, black arrow a non-TH/non-GFP/retrogradely 
labeled cell), here from an injection into central amygdala. J-K) Images of injections of 
Retrobeads (J) or FG (K) centered in LHb display spread of injection.  Scale bars in D = 50 µm; 
in H, I = 20 µm; in J, K = 100 µm. 
 
Figure 8. Diagrams of infusion sites of retrograde tracers.  Tracers were infused into seven 
locations in GAD67-GFP knock-in mice to verify GABAergic projections.  The center and 
spread of the tracer of a representative infusion for each target area are indicated by the filled and 
shaded regions, respectively.  Some infusions had some minor overlap with adjacent regions. 
 
Figure 9. Coronal diagrams from rostral to caudal (A, C, E, G, I) levels of the VTA showing the 
location of GABA projection neurons by retrograde tracing.  Panels A, C, E, G and I display 
cells from representative cases of infusions of tracer into NAcc Shell (filled circles), NAcc Core 
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(filled squares), mPFC (filled triangles) and amygdala (filled diamonds).  Panels B, D, F, H, and 
J display mark cells from cases of tracer infused into LHb (open circles), VP/BNST (open 
squares) and MCPO/OT (open triangles). The majority of retrogradely labeled VTA GABA 
neurons are found in the lateral and ventral regions of the VTA. 
 
Figure 10. Graphs indicating the percentage of retrogradely labeled cells within each VTA 
subregion by infusion target by neurotransmitter phenotype. Panels in the left column (A, C, E, 
G, I) contain data from GAD67-GFP mice.  Panels in the right column (B, D, F, H, J) contain 
data from VGluT2-IRES-Cre mice.  The average number of retrogradely labeled cells per animal 
is contained in each column.  Black indicates the percentage co-labeled for TH, black with gray 
stripes indicates the percentage labeled with TH and VGluT2 (VGluT2-IRES-Cre mice), gray is 
the percentage co-labeled for GFP (in GAD67-GFP mice) or negative for TH and VGluT2 (in 
VGluT2-IRES-Cre mice), and white is the percentage labeled for VGluT2 only (VGluT2-IRES-
Cre mice) or negative for both TH and GFP (GAD67-GFP mice).      
 
Figure 11. Retrograde tracing in VGluT2-IRES-Cre mice.  Infusion of FG into MCPO (A-D) or 
LHb (E-H) and AAV-DIO-Ef1a-mCherry into the VTA revealed several types of projections: 
FG/TH only, FG/TH/VGluT2 (black arrowheads), FG/VGluT2 only (black arrows), and FG only 
(white arrowheads).  Panels A-D show cells in the interfascicular nucleus, and panels E-H are 
from the parabrachial pigmented nucleus.  Scale bars = 20 µm. 
 
Figure 12. Coronal diagrams from rostral to caudal (top to bottom) levels of VTA showing the 
location of retrogradely labeled VGluT2-only neurons. One representative case from each 
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injection site was mapped to demonstrate the location of projection neurons throughout the 
rostral-caudal axis of the VTA.  TH+/retrogradely labeled cells were not depicted for clarity and 
to emphasize the non-dopaminergic projections.  Note the majority of VGluT2-only projections 
originate from the medial nuclei (RLi and IF) and the medial portions of PBP and PN.   
 
Figure 13. Summary diagram of VTA GABAergic (Panel A) and glutamatergic (Panel B) 
efferents.  The thickness of the arrows roughly depicts the density of the projection.    
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Table 1. Viruses used for identification and tracing of GABAergic neurons 
 
Virus Purpose Amount Source 
AAV-Ef1a-DIO-hChR2-eYFP Label axonal projections 0.2-0.3 µl; unilateral UNC Vector Core 
AAV-Ef1a-DIO-hChR2-mCherry Label axonal projections 0.2-0.3 µl; unilateral UNC Vector Core 
AAV-Ef1a-DIO-mCherry Label cell bodies in infusion 
site 
0.5 µl; unilateral UNC Vector Core 
AAV-Ef1a-DIO-Syb2-GFP Enrich labeling in synaptic 
terminals 
0.2 µl; unilateral Ralph DiLeone  
 
AAV – adeno-associated virus; EF1a- elongation factor 1a promoter; DIO – double floxed inverse open 
reading frame; hChR2 - channelrhodopsin 
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Table 2. Primary Antibodies 
 
Antibody Name Immunogen Manufacture
r 
Host Clonality Dilution 
TH Denatured TH from rat 
pheochromocytoma 
(SDS) 
Millipore; 
AB152 
Rabbit Polyclonal 1:1000 
      
TH Native TH from rat 
pheochromocytoma 
Millipore; 
AB1542, Lot# 
NG1861500 
 
Sheep Polyclonal 1:1000 
 
TH 
 
Two synthetic peptides; 
one from amino acids 1-
100 of mouse tyrosine 
hydroxylase, one from 
amino acids 398-498 of 
mouse tyrosine 
hydroxylase 
 
Pierce; PA1-
46351 
Chicken Polyclonal 1:1000 
GFP Recombinant full length 
protein (eGFP) 
Abcam; 
ab13970 
Chicken Polyclonal 1:1500 
      
Choline 
Acetyltransferase 
(ChAT) 
Human placental 
Choline 
acetyltransferase 
Chemicon; 
AB144P 
Goat Polyclonal 1:500 
      
dsRed Full-length dsRed-
Express 
ClonTech;  
632496 
Rabbit Polyclonal 1:500 
      
VGAT Synthetic 17 amino acid 
peptide -  
VHSLEGLIEAYRTNA
ED - corresponding to C 
terminus of rat VGAT 
Millipore; 
AB5602P 
Rabbit Polyclonal 1:1000 
      
VGluT2 Recombinant GST-
tagged VGluT2 
Millipore; 
AB2251 
Guinea Pig Polyclonal 1:500 
      
Substance P Synthetic Substance P 
coupled to KLH with  
Carbodiimide 
ImmunoStar Rabbit Polyclonal 1:500 
      
FluoroGold FluoroGold FluoroChrome Rabbit Polyclonal 1:500 
 
GAD67 
 
Synthetic peptide - C-
PDSPQRREKLHK 
corresponding to amino 
acids 526-537 of human 
GAD67 
 
Abcam; 
ab80589 
 
Goat 
 
Polyclonal 
 
1:500 
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Table 3. Relative Density of GABAergic Fibers in Various Brain Structures After AAV-Ef1a-DIO-ChR2-eYFP 
Injection into the VTA from Several Cases.  
                                  GAD65-IRES-Cre              GAD67-Cre 
Brain Structure S2 S3 S4 GC 120 GC 122 GC 153 
 
Cortex 
   Prelimbic 
   Infralimbic 
   Dorsal peduncular 
   Dorsal tenia tecta 
   Piriform 
Claustrum 
Endopiriform Nucleus 
Striatum 
   Nucleus Accumbens Shell 
   Nucleus Accumbens Core 
   Major Island of Calleja 
   Caudate/Putamen 
Olfactory Tubercle 
Ventral Pallidum 
Substantia Innominata 
Septum 
   Lateral Septum, dorsal 
   Lateral Septum, intermediate 
   Medial Septum 
   Diagonal Band of Broca 
Bed Nucleus of Stria Terminalis 
Interstitial Nucleus of Posterior Anterior   Commissure 
Hypothalamus 
   Medial preoptic area 
   Lateral preoptic area 
   Magnocellular preoptic area 
   Lateral hypothalamic area 
   Dorsomedial hypothalamic area 
Lateral Globus Pallidus 
Thalamus/epithalamus 
   Paratenial thalamic nucleus 
   Paraventricular thalamic nucleus 
   Ventromedial thalamic nucleus 
   Mediodorsal thalamic nucleus 
   Intermediodorsal thalamic nucleus 
   Lateral habenula 
   Reticular thalamic nucleus 
   Central medial thalamic nucleus 
   Parafascicular thalamic nucleus 
Zona Incerta 
Sublenticular extended amygdala 
Amygdala 
   Central amygdala    
   Basolateral amygdala 
   Basomedial amygdala 
Midbrain 
   Superior Colliculus 
   Periaqueductal Gray 
   Substantia Nigra 
   Deep Mesencephalic Nucleus 
   Retrorubral Field 
Pons and Medulla 
   Dorsal Raphe 
   Raphe Cap 
   Median Raphe 
   Paramedian Raphe 
   Anterior tegmental nucleus 
   Pedunculopontine nucleus 
   Laterodorsal tegmental nucleus 
   Locus Coeruleus 
   Supraoculomotor Nucleus 
   External cortex of inferior colliculus 
   Medioventral periolivary nucleus 
   Lateral parabrachial nucleus 
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Table 4. Percentage of retrogradely-labeled cells in VGluT2-IRES-Cre mice according to putative 
neurotransmitter phenotype. 
 
VTA 
Subnucleus 
Retrograde 
Infusion FG/TH  FG/TH/VGluT2 FG/VGluT2 
FG/TH(-)/ 
VGluT2(-) 
 
na 
Rli NAcc Shell 43% 14% 0% 43% 3.5 
NAcc Core 10% 0% 60% 30% 5 
LHb 0% 4% 69% 27% 26 
VP 17% 10% 49% 23% 132 
PFC 13% 6% 35% 45% 15.5 
Amyg 0% 58% 17% 25% 6 
  MCPO 1% 3% 87% 8% 103.5 
If NAcc Shell 51% 25% 5% 18% 38 
NAcc Core 29% 26% 40% 6% 17.5 
LHb 0% 0% 78% 22% 29 
VP 9% 26% 60% 5% 93 
PFC 6% 6% 31% 56% 8 
Amyg - - - - 0 
  MCPO 2% 12% 80% 6% 25.5 
PBP NAcc Shell 54% 28% 12% 6% 108.5 
NAcc Core 43% 29% 15% 13% 78.5 
LHb 8% 1% 69% 22% 37 
VP 45% 18% 18% 19% 297 
PFC 59% 15% 15% 11% 69.5 
Amyg 15% 60% 12% 13% 54 
  MCPO 40% 22% 23% 16% 186 
PN NAcc Shell 38% 52% 4% 5% 45.5 
NAcc Core 35% 43% 16% 5% 18.5 
LHb 0% 0% 0% 100% 1 
VP 20% 53% 22% 5% 99 
PFC 14% 71% 10% 5% 10.5 
Amyg 0% 81% 13% 6% 8 
  MCPO 12% 79% 6% 3% 16.5 
Cli NAcc Shell 94% 0% 0% 6% 8.5 
NAcc Core 36% 36% 11% 18% 14 
LHb 0% 0% 55% 45% 5.5 
VP 35% 16% 6% 43% 51 
PFC 85% 8% 0% 8% 6.5 
Amyg 8% 85% 0% 8% 6.5 
MCPO 11% 69% 6% 14% 18 
na = average number of total retrogradely labeled cells from two animals per infusion region.  These numbers were 
used to calculate the percentages listed.  
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Table 5. Percentage of VTA cell types containing retrograde tracers (FluoroGold or Retrobeads) 
 
VTA 
Subregion 
 
 
Retrograde 
Infusion 
 
 
Percent of  
GFP+ neurons  
with tracer 
 
Percent of TH 
only neurons  
with tracer 
 
Percent of 
TH/VGluT2  
neurons with 
tracer 
Percent of  
VGluT2 only  
neurons with  
tracer 
Rli NAcc Shell 0% 13% 14% 0% 
NAcc Core 0% 11% 0% 1% 
LHb 2% 0% 5% 7% 
VP/BNST 15% 47% 33% 26% 
PFC 0% 9% 15% 3% 
Amyg 0% 0% 18% 0% 
MCPO/OT 9% 18% 10% 33% 
If NAcc Shell 14% 58% 51% 1% 
NAcc Core 0% 56% 20% 4% 
LHb 5% 0% 0% 15% 
VP/BNST 9% 80% 55% 35% 
PFC 0% 2% 3% 2% 
Amyg 0% 0% 0% 0% 
MCPO.OT 0% 14% 7% 12% 
PBP NAcc Shell 4% 25% 32% 4% 
NAcc Core 1% 18% 22% 4% 
LHb 10% 1% 0% 9% 
VP/BNST 18% 38% 40% 24% 
PFC 2% 12% 11% 5% 
Amyg 3% 2% 18% 2% 
MCPO/OT 12% 24% 34% 18% 
PN NAcc Shell 4% 42% 58% 5% 
NAcc Core 1% 33% 19% 5% 
LHb 6% 0% 0% 0% 
VP/BNST 13% 77% 74% 37% 
PFC 3% 3% 15% 2% 
Amyg 3% 0% 8% 2% 
MCPO/OT 2% 12% 28% 3% 
Cli NAcc Shell 3% 28% 0% 0% 
NAcc Core 0% 20% 29% 7% 
LHb 7% 0% 0% 12% 
VP/BNST 3% 44% 67% 30% 
PFC 0% 13% 3% 0% 
Amyg 0% 1% 16% 0% 
MCPO/OT 1% 6% 25% 4% 
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Figure 1. GAD-Cre animals allow for cell-specific anterograde tracing.  Infusion of AAV-Ef1a-DIO-mCherry 
permits visualization of Cre-expressing cells in the ventral tegmental area (VTA; panels A, E).  Many Cre-
expressing cells in GAD67-Cre (A-D) and GAD65-IRES-Cre mice (E-H) clearly stain for GAD67 and lack 
tyrosine hydroxylase, a marker of dopamine neurons (white arrows).  GABAergic Cre+ cells are present 
throughout the subregions of the VTA (Panel I).  J) An example infusion site for anterograde tracing 
demonstrating labeling centered in the VTA (Case S2, used for Figures 3 and 5) Scale bars in panels D, H, I 
= 50 µm, in panel J = 200 µm.  
171x152mm (300 x 300 DPI)  
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Figure 2. Injection sites for five cases (three restricted almost entirely to VTA, two control infusions) of viral 
infusion into GAD-Cre animals for anterograde tracing.  Coronal drawings from rostral (top) to caudal VTA 
(bottom) depict the spread of virus (as detected by transduced cell bodies). Each dot represents an eYFP-
expressing cell body transduced by the virus.  Cases GC 152, 153, and 116 are GAD67-Cre mice, and Cases 
S2 and S3 are GAD65-IRES-Cre mice.  In case GC 152, the infusion was restricted to the red nucleus, dorsal 
to the VTA, and in case GC 116 the infusion was centered in the interpeduncular nucleus, ventral to the VTA. 
165x214mm (300 x 300 DPI)  
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Figure 2 plate 2  
118x182mm (300 x 300 DPI)  
 
 
Page 55 of 70
John Wiley & Sons
Journal of Comparative Neurology
  
 
 
Figure 3. Panels showing anterograde labeled GABAergic fibers from case S2, which had an infusion of virus 
driving channelrhodopsin-eYFP, stained for eYFP (green) and TH (magenta).  Panels A, D, G, and J show 
diagrams of forebrain sections containing labeled fibers.  Black boxes indicate the regions shown in B, E, H, 
and K.  Panels C, F, I, and L differ from B, D, F, and H only in the addition of the TH channel to delineate 
brain regions.  Inset in Panel E shows the varicose nature of the fibers in surrounding the island of Calleja 
(scale bar = 10 µm).  Note the largely non-overlapping patterns of GABAergic fibers and TH labeling.  Scale 
bars in in C, F, I, L = 100 µm.  
170x228mm (300 x 300 DPI)  
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Figure 4. Coronal diagrams of line drawings of labeled fibers in representative cases from similar levels in 
both GAD65-IRES-Cre mice (Case S3; A, C, E, G, I, K, M, O) and GAD67-Cre mice (Case GC 153; B, D, F, H, 
J, L, N, P).    
171x230mm (300 x 300 DPI)  
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Figure 4 plate 2  
171x230mm (300 x 300 DPI)  
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Figure 5. Panels showing images from more caudal areas of case S2 stained for channelrhodopsin-eYFP 
(green), TH (magenta) and ChAT (blue).  Panels B, E, H, and K are enlargements of the areas outlined in A, 
D, G and J, respectively.  Scale bars = 100 µm.    
171x228mm (300 x 300 DPI)  
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Figure 6. Ventral tegmental area GABA neurons make contact with cholinergic and non-cholinergic 
neurons.  A) Low magnification projection image depicting GABAergic fibers apposing cholinergic cellular 
profiles (white arrowheads) and non-cholinergic regions (white arrows) in nucleus accumbens core (from 
case S2).  B) High magnification projection image of outlined region in panel A.  Note how the labeled fibers 
follow the proximal dendrites and contain several varicosities that appose the cell body and dendrites of 
cholinergic neurons.  C) Triple labeling in nucleus accumbens shell for fibers, cholinergic cells and NeuN to 
reveal all neuronal nuclei suggest that GABA fibers may make similar appositions and encapsulations around 
non-cholinergic cells (white arrow, see white arrows in panel A).  D) Co-localization of YFP+ varicosities and 
boutons with immunolabeling of the vesicular GABA transporter, which is localized to inhibitory synapses, 
indicates that these fibers are indeed GABAergic and make inhibitory connections.  This image is from the 
lateral habenula of case S2. Similar co-labeling with VGAT is seen in LHb, CeA, VP, NAcc and VTA of both 
GAD67-Cre and GAD65-IRES-Cre mice.  Orthogonal views are of the bouton nearest the scale bar in lower 
right.  Scale bars in A = 50 µm; B, C = 10 µm; D = 5 µm.  
154x153mm (300 x 300 DPI)  
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Figure 7. Retrograde tracing in GAD67-GFP knock-in mice.  A-D) GFP+ cells in the VTA show 
immunohistochemical markers of GABA neurons (white arrows).  Most, but not all GFP+ neurons (black 
arrowheads), clearly stain for GAD67 and lack TH immunoreactivity.  Some are at the same level as 
surrounding neuropil.  E-H) Injection of FluoroGold (FG) into the magnocellular preoptic nucleus revealed 
three classes of VTA projections: FG/TH (dopaminergic), FG/GFP (white arrowheads, GABAergic) and FG+ 
only (black arrows, TH- and GFP-; non-DA, non-GABA).  I) Injections of Red Retrobeads gave similar results 
(white arrowhead shows a GFP+/retrogradely labeled cell, black arrow a non-TH/non-GFP/retrogradely 
labeled cell), here from an injection into central amygdala. J-K) Images of injections of Retrobeads (J) or FG 
(K) centered in lateral habenula display spread of injection.  Scale bars in D = 50 µm; in H, I = 20 µm; in J, 
K = 100 µm.  
171x143mm (300 x 300 DPI)  
 
 
Page 61 of 70
John Wiley & Sons
Journal of Comparative Neurology
  
 
 
Figure 8. Diagrams of infusion sites of retrograde tracers.  Tracers were infused into seven locations in 
GAD67-GFP knock-in mice to verify GABAergic projections.  The center and spread of the tracer of a 
representative infusion for each target area are indicated by the filled and shaded regions, 
respectively.  Some infusions had some minor overlap with adjacent regions.  
171x115mm (300 x 300 DPI)  
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Figure 9. Coronal diagrams from rostral to caudal (A, C, E, G, I) levels of the VTA showing the location of 
GABA projection neurons by retrograde tracing.  Panels A, C, E, G and I display cells from representative 
cases of infusions of tracer into NAcc Shell (filled circles), NAcc Core (filled squares), mPFC (filled triangles) 
and amygdala (filled diamonds).  Panels B, D, F, H, and J display mark cells from cases of tracer infused into 
LHb (open circles), VP/BNST (open squares) and MCPO/OT (open triangles). The majority of retrogradely 
labeled VTA GABA neurons are found in the lateral and ventral regions of the VTA.  
109x189mm (300 x 300 DPI)  
 
 
Page 63 of 70
John Wiley & Sons
Journal of Comparative Neurology
  
 
 
Figure 10. Graphs indicating the percentage of retrogradely labeled cells within each VTA subregion by 
infusion target by neurotransmitter phenotype. Panels in the left column (A, C, E, G, I) contain data from 
GAD67-GFP mice.  Panels in the right column (B, D, F, H, J) contain data from VGluT2-IRES-Cre mice.  The 
average number of retrogradely labeled cells per animal is contained in each column.  Black indicates the 
percentage co-labeled for TH, black with gray stripes indicates the percentage labeled with TH and VGluT2 
(VGluT2-IRES-Cre mice), gray is the percentage co-labeled for GFP (in GAD67-GFP mice) or negative for TH 
and VGluT2 (in VGluT2-IRES-Cre mice), and white is the percentage labeled for VGluT2 only (VGluT2-IRES-
Cre mice) or negative for both TH and GFP (GAD67-GFP mice).  
279x387mm (300 x 300 DPI)  
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Figure 10 plate 2  
211x221mm (300 x 300 DPI)  
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Figure 11. Retrograde tracing in VGluT2-IRES-Cre mice.  Infusion of FG into MCPO (A-D) or LHb (E-H) and 
AAV-DIO-Ef1a-mCherry into the VTA revealed several types of projections: FG/TH only, FG/TH/VGluT2 
(black arrowheads), FG/VGluT2 only (black arrows), and FG only (white arrowheads).  Panels A-D show cells 
in the interfascicular nucleus, and panels E-H are from the parabrachial pigmented nucleus.  Scale bars = 20 
µm.  
171x85mm (300 x 300 DPI)  
 
 
Page 66 of 70
John Wiley & Sons
Journal of Comparative Neurology
  
 
 
Figure 12. Coronal diagrams from rostral to caudal (top to bottom) levels of VTA showing the location of 
retrogradely labeled VGluT2-only neurons. One representative case from each injection site was mapped to 
demonstrate the location of projection neurons throughout the rostral-caudal axis of the 
VTA.  TH+/retrogradely labeled cells were not depicted for clarity and to emphasize the non-dopaminergic 
projections.  Note the majority of VGluT2-only projections originate from the medial nuclei (RLi and IF) and 
the medial portions of PBP and PN.    
155x189mm (300 x 300 DPI)  
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Figure 13. Summary diagram of ventral tegmental area GABAergic (Panel A) and glutamatergic (Panel B) 
efferents.  The thickness of the arrows roughly depicts the density of the projection.    
81x90mm (300 x 300 DPI)  
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Graphical Abstract Text 
 
Cell-specific anterograde tracing and retrograde tracing revealed that GABAergic and 
glutamatergic neurons from the ventral tegmental area project to limbic structures throughout 
the forebrain and brainstem.  The GABAergic projections were concentrated in areas that 
received minor dopaminergic innervation, suggesting functions for ventral midbrain GABA 
neurons independent of local dopamine neuron inhibition.   
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GABAergic projections were concentrated in areas that received minor dopaminergic innervation, suggesting 
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